Merck & Co., Inc. Preferred Stock, Dividend Rate, Percentage
Merck & Co., Inc. (MRK) reported Preferred Stock, Dividend Rate, Percentage of 5.00% for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-27.
Discontinued › Notes › Equity › Stockholders' Equity Note › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDividendRatePercentage · last filed 2016-02-26
- Merck & Co., Inc. preferred stock, dividend rate, percentage for the quarter ending 2013-03-31 was 5.00%, a 0.00% change year-over-year.
- Merck & Co., Inc. preferred stock, dividend rate, percentage for the quarter ending 2012-03-31 was 5.00%.
- Merck & Co., Inc. preferred stock, dividend rate, percentage for fiscal 2013 was 5.00%.
- Merck & Co., Inc. preferred stock, dividend rate, percentage for fiscal 2010 was 6.00%, a 0.00% change from fiscal 2009.
- Merck & Co., Inc. preferred stock, dividend rate, percentage for fiscal 2009 was 6.00%.
- Merck & Co., Inc. preferred stock, dividend rate, percentage for fiscal 1998 was 5.00%.
| Period end | Preferred Stock, Dividend Rate, Percentage 3 month | Preferred Stock, Dividend Rate, Percentage 6 month | Preferred Stock, Dividend Rate, Percentage 7 month | Preferred Stock, Dividend Rate, Percentage 9 month | Preferred Stock, Dividend Rate, Percentage 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | 5.00% 10-K · filed 2014-02-27 | ||||
| 2013-03-31 | 5.00% 10-Q · filed 2013-05-09 | ||||
| 2012-09-30 | 5.00% 10-Q · filed 2012-11-09 | ||||
| 2012-06-30 | 5.00% 10-Q · filed 2012-08-07 | ||||
| 2012-03-31 | 5.00% 10-Q · filed 2012-05-08 | ||||
| 2010-12-31 | 6.00% 10-K · filed 2012-02-28 | ||||
| 2010-08-13 | 6.00% 10-K · filed 2012-02-28 | ||||
| 2009-12-31 | 6.00% 10-K · filed 2012-02-28 | ||||
| 1998-12-31 | 5.00% 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |